Register a supplement in Germany and you can probably sell it in France, with caveats, and definitely not in every other EU market without more work. The single European market is single for goods, not for supplement dossiers. Here is the practical reality of multi-market registration.
The myth of “one EU registration”
The EU sets the framework via Directive 2002/46/EC, but each of the 27 member states transposes that directive into national law and runs its own notification procedure. Germany’s BVL works one way, Italy’s Ministry of Health another, France’s DGCCRF another. Belgium and Netherlands have particularly strict ingredient lists.
What is universal: the principle of mutual recognition. A product legally sold in one EU market generally has a path to sell in others, but each market’s authority still usually has to be notified that the product is being placed on it.
The four notification archetypes
1. Notification with submission of documentation
Italy, Belgium, France, and several others require a complete dossier (label, formula, scientific substantiation for any claims) and an authority response before sale. Timelines: 30–90 days.
2. Notification only (no documentation review)
Some markets require notification with a link to the label and the product details, but the authority does not pre-review. Sale can start on notification. Timelines: same week.
3. No notification (mutual recognition only)
A few markets accept products legally placed in another EU state without their own notification. A Mutual Recognition Declaration stays on file in case it is challenged.
4. Cosmetics (different framework entirely)
For cosmetic creams, our ISO 22716 line, the EU runs the Cosmetic Products Notification Portal (CPNP). One central notification plus a Cosmetic Product Safety Report (CPSR) signed by a qualified Safety Assessor. Faster than supplements: typically 1–2 weeks.
How a “file once” workflow actually works
This is how our regulatory team takes one of our products into several EU markets:
- Master dossier built once: formula, manufacturing flow, finished product specification, stability data, allergen statements, supplier qualification, certificate of analysis template.
- Per-market label adaptation: the master label is translated and adjusted to local law (Belgian labels need French + Dutch + German, for example).
- Per-market filing: we submit the local notification with the adapted label and the master dossier behind it.
- Authority follow-up: if a market raises questions, we answer them. The people who wrote the specification are the people who reply.
- Active dossier maintenance: the dossier is updated whenever the formulation, a supplier or a specification changes.
Work to enter a new market once the master dossier exists: usually 2–6 weeks per market. The first market is the heaviest lift by a wide margin.
The U.K. is its own thing now
Post-Brexit, the U.K. operates separately. Supplements must comply with U.K. law, largely retained EU regulation but steadily diverging. Cosmetics use the U.K. SCPN portal instead of CPNP. U.K. notifications are a separate workstream from day one.
How we sequence our own launches
That is 29 regimes in total: 27 EU member states, the United Kingdom, and the United States. Nobody files into all of them at once, and the dossier work is only half the cost. Today we sell one product, PureNADH, in the United States, with more in development.
The order we work in:
- The market where the product has real demand. A dossier for a market with no customers is an expense with no return.
- One adjacent EU market, to learn the cross-border mechanics on a small footprint before repeating them.
- The U.K., where shared language and retained EU rules make the lift smaller than it looks.
- The U.S., which asks for no pre-market notification but the most label discipline.
Filing all 27 EU markets plus the U.K. and the U.S. at once is possible, and the master dossier is deliberately built so it could be done. That is a budget decision, not a regulatory one.